Events and Presentations
Guggenheim Healthcare Talks—Genomic Medicines and Rare Disease Day Conference
- Panel on Duchenne Muscular Dystrophy (DMD) - Participants include:
- Arthur Levin, PhD, Chief Scientific Officer, Avidity Biosciences
- Michael Binks, MD, Vice President of Clinical Research, Pfizer
- Louise Rodino-Klapac, PhD, Chief Scientific Officer, Sarepta Therapeutics
- Carl Morris, PhD, Chief Scientific Officer, Solid Biosciences
- Sam Wadsworth, Chief Scientific Officer, Ultragenyx Pharmaceutical